Entegris Total Revenue decreased by 1.5% to $811.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $773.20M to $811.90M. Over 4 years (FY 2021 to FY 2025), Total Revenue shows an upward trend with a 8.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $571.35M | $579.49M | $635.20M | $649.65M | $692.49M | $993.83M | $946.07M | $922.40M | $901.00M | $888.24M | $812.29M | $771.00M | $812.70M | $807.70M | $849.80M | $773.20M | $792.40M | $807.10M | $823.90M | $811.90M |
| QoQ Change | — | +1.4% | +9.6% | +2.3% | +6.6% | +43.5% | -4.8% | -2.5% | -2.3% | -1.4% | -8.6% | -5.1% | +5.4% | -0.6% | +5.2% | -9.0% | +2.5% | +1.9% | +2.1% | -1.5% |
| YoY Change | — | — | — | — | +21.2% | +71.5% | +48.9% | +42.0% | +30.1% | -10.6% | -14.1% | -16.4% | -9.8% | -9.1% | +4.6% | +0.3% | -2.5% | -0.1% | -3.0% | +5.0% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Fabs | $473.10M | $489.10M | $494.50M | $516.30M | $493.20M |
| Equipment and Engineering | $112.90M | $119.50M | $115.20M | $121.80M | $136.20M |
| Chemical and Materials | $78.10M | $76.90M | $81.30M | $83.80M | $85.80M |
| Semi Distributor and Other | — | — | $75.00M | $61.70M | $50.10M |
| Non-Semi | $39.10M | $41.10M | $41.10M | $40.30M | $46.60M |
| Total | $773.20M | $792.40M | $807.10M | $823.90M | $811.90M |
| Segment | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| APS | — | — | — | — | — | $460.80M | $464.50M | $463.60M |
| MS | — | — | $350.00M | $342.30M | $346.70M | $348.60M | $361.80M | $351.10M |
| Advanced Materials Handling AMH | $180.25M | $169.19M | $162.85M | $188.23M | $182.18M | — | — | — |
| Materials Sciences | $435.54M | — | — | — | — | — | — | — |
| Microcontamination Control | $286.22M | — | — | — | — | — | — | — |
| Microcontamination Control MC | — | $288.43M | $267.86M | $293.77M | $287.00M | — | — | — |
| Total | $888.24M | $812.29M | $771.00M | $812.70M | $807.70M | $807.10M | $823.90M | $811.90M |
Advanced Materials Handling AMH, Advanced Planarization Solutions, Materials Sciences, Microcontamination Control, Microcontamination Control MC, Specialty Chemicals and Electronic Materials SCEM were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q1 '22 | Q2 '22 | Q4 '24 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|---|
| Semi Distributor/Other | $85.89M | $85.89M | — | $70.00M | $65.80M |
| Equipment and Engineerig | $136.99M | $136.99M | $123.38M | — | — |
| Total | $649.65M | $692.49M | $849.80M | $773.20M | $792.40M |
Equipment and Engineerig is derived from annual filings.
Equipment and Engineerig, Semi Distributor/Other were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| North America | — | — | — | — | — | — | — | $134.50M |
| Southeast Asia | $57.60M | $61.70M | $62.20M | $60.90M | $60.40M | $61.60M | $73.20M | $68.20M |
| Europe | $69.10M | $68.10M | $65.00M | $62.00M | $57.50M | $57.50M | $62.50M | $54.40M |
| Total | $812.70M | $807.70M | $849.80M | $773.20M | $792.40M | $807.10M | $823.90M | $811.90M |